Soumya Raychaudhuri

Brigham and Women's Hospital

NIH Rank #1926
  • Program Leader
  • R01 Holder
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$3.6M
Fiscal year 2024
Grants Awarded
7
Active NIH grants
National Rank
#1,926
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3.6M across 7 grants · National rank #1926.

Top grants by award amount

Soumya Raychaudhuri's NIH grant portfolio, ranked by award amount.

  • 5U01HG012009-04U01
    Predicting the impact of genetic variants, genes and pathways on human Disease
    $773.2K
    award amount
  • 5UC2AR081023-03UC2
    Integrative analysis of high dimensional tissue molecular data to define key biological systems in autoimmune diseases (SBC)
    $636.8K
    award amount
  • 5P01AI148102-04P01
    Differentiation of immune cells and fibrobalsts in inflamed tissue in RA and SLE
    $609.6K
    award amount
  • 1R01HG013083-01A1R01
    Integrative modelling of single-cell data to elucidate the genetic architecture of complex disease
    $507.2K
    award amount
  • 5R01AR063759-09R01
    Defining the influence of RA genetic susceptibility factors on T cell antigen specificity and functional state
    $479.4K
    award amount
  • 5U19AI095219-14U19
    Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease
    $318K
    award amount
  • 5R01AR063709-09R01
    Expanded fibroblast subset drives pathology in rheumatoid arthritis
    $282.1K
    award amount

Affiliations

Institutions that have administered grants for Soumya Raychaudhuri.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Brigham and Women's Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1926
  6. 2024
    Entered Top 25% Nationally
    Ranked #1926
  7. 2024
    Entered Top 10% Nationally
    Ranked #1926
  8. 2024
    Multi-Institutional Research
    Awards at 2 institutions